Morais, M.; Fonseca, T.; Melo-Pinto, D.; Prieto, I.; Vilares, A.T.; Duarte, A.L.; Leitão, P.; Cirnes, L.; Machado, J.C.; Carneiro, S.
Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study. Pharmaceuticals 2023, 16, 427.
https://doi.org/10.3390/ph16030427
AMA Style
Morais M, Fonseca T, Melo-Pinto D, Prieto I, Vilares AT, Duarte AL, Leitão P, Cirnes L, Machado JC, Carneiro S.
Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study. Pharmaceuticals. 2023; 16(3):427.
https://doi.org/10.3390/ph16030427
Chicago/Turabian Style
Morais, Marina, Telma Fonseca, Diogo Melo-Pinto, Isabel Prieto, Ana Teresa Vilares, Ana LuÃsa Duarte, PatrÃcia Leitão, LuÃs Cirnes, José Carlos Machado, and Silvestre Carneiro.
2023. "Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study" Pharmaceuticals 16, no. 3: 427.
https://doi.org/10.3390/ph16030427
APA Style
Morais, M., Fonseca, T., Melo-Pinto, D., Prieto, I., Vilares, A. T., Duarte, A. L., Leitão, P., Cirnes, L., Machado, J. C., & Carneiro, S.
(2023). Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study. Pharmaceuticals, 16(3), 427.
https://doi.org/10.3390/ph16030427
